← Leaderboards
Jennifer L Nelms
Geovax, Inc.
$1,303,014
Attributed
$1,303,014
Total exposure
2
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding mix
By agency
NIH$1,303,014 · 2
By mechanism
U19$1,203,014 · 1
R03$100,000 · 1
Top collaborators
No co-investigators on record.
Most similar at Geovax, Inc.
Same institution · by research overlap
- Robert T McNally$7,369,398
- Arban Domi$593,623
- Jack R Berg$100,000
- Sue Fen Kwa$276,690
Others in their field
Top investigators on “Vector Vaccine”
- Lawrence Corey · Fred Hutchinson Cancer Center$446,547,761
- Glenda E Gray · Wits Health Consortium (Pty), Ltd$239,426,049
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$142,420,923
- Peter B. Gilbert · Fred Hutchinson Cancer Center$124,587,333
- Louis J. Picker · Oregon Health And Science University$70,366,260
- David Heimbrook · Leidos Biomedical Research, Inc.$68,561,099
Research focus
Vector VaccineIndiaAids VaccinesAdjuvantAgreementClinical TrialsAfrica, SouthernAsiaBiologicalCause Of DeathCell LineCenters For Disease Control And Prevention (U.S.)ConceptClinical Trials, Phase ICommunicationAntigensConditionContractsCountryCyclic GmpDna/Mva VaccineDoxorubicin/Mitomycin/Vinblastine ProtocolFacility Construction Funding CategoryAfrica